Work

Pathological complete response in early stage HER-2 positive breast cancer patients, receiving neoadjuvant chemotherapy/ Trastuzumab, in a single breast unit in Johannesburg

Year: 2021

Type: article

Source: The Breast

DOI: 10.1016/s0960-9776(21)00178-8

Authors: A. Bellomo, C. Benn, T. Smit, L. Heyman, B. Rapoport

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,100

OpenAlex ID: W3136768331

FWCI: 0.2

Cites: 4

Cited by: 2

Related to: 10